Huhn Evelyn A, Göbl Christian S, Fischer Thorsten, Todesco Bernasconi Monya, Kreft Martina, Kunze Mirjam, Vogt Deborah R, Dölzlmüller Eva, Jaksch-Bogensperger Heidi, Heldstab Sandra, Eppel Wolfgang, Husslein Peter, Ochsenbein Kölble Nicole, Richter Anne, Bäz Elke, Winzeler Bettina, Hoesli Irene
Department of Feto-Maternal Medicine and Obstetrics, University Hospital Basel, Basel, Switzerland.
Department of Prenatal Diangosis and Obstetrics, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
BMJ Med. 2023 Sep 13;2(1):e000330. doi: 10.1136/bmjmed-2022-000330. eCollection 2023.
To evaluate the predictability of gestational diabetes mellitus wth a 75 g oral glucose tolerance test (OGTT) in early pregnancy, based on the 2013 criteria of the World Health Organization, and to test newly proposed cut-off values.
International, prospective, multicentre cohort study.
Six university or cantonal departments in Austria, Germany, and Switzerland, from 1 May 2016 to 31 January 2019.
Low risk cohort of 829 participants aged 18-45 years with singleton pregnancies attending first trimester screening and consenting to have an early 75 g OGTT at 12-15 weeks of gestation. Participants and healthcare providers were blinded to the results.
Fasting, one hour, and two hour plasma glucose concentrations after an early 75 g OGTT (12-15 weeks of gestation) and a late 75 g OGTT (24-28 weeks of gestation).
Of 636 participants, 74 (12%) developed gestational diabetes mellitus, according to World Health Organization 2013 criteria, at 24-28 weeks of gestation. Applying WHO 2013 criteria to the early OGTT with at least one abnormal value gave a low sensitivity of 0.35 (95% confidence interval 0.24 to 0.47), high specificity of 0.96 (0.95 to 0.98), positive predictive value of 0.57 (0.41 to 0.71), negative predictive value of 0.92 (0.89 to 0.94), positive likelihood ratio of 10.46 (6.21 to 17.63), negative likelihood ratio of 0.65 (0.55 to 0.78), and diagnostic odds ratio of 15.98 (8.38 to 30.47). Lowering the postload glucose values (75 g OGTT cut-off values of 5.1, 8.9, and 7.8 mmol/L) improved the detection rate (53%, 95% confidence interval 41% to 64%) and negative predictive value (0.94, 0.91 to 0.95), but decreased the specificity (0.91, 0.88 to 0.93) and positive predictive value (0.42, 0.32 to 0.53) at a false positive rate of 9% (positive likelihood ratio 5.59, 4.0 to 7.81; negative likelihood ratio 0.64, 0.52 to 0.77; and diagnostic odds ratio 10.07, 6.26 to 18.31).
The results of this prospective low risk cohort study indicated that the 75 g OGTT as a screening tool in early pregnancy is not sensitive enough when applying WHO 2013 criteria. Postload glucose values were higher in early pregnancy complicated by diabetes in pregnancy. Lowering the postload cut-off values identified a high risk group for later development of gestational diabetes mellitus or those who might benefit from earlier treatment. Results from randomised controlled trials showing a beneficial effect of early intervention are unclear.
ClinicalTrials.gov NCT02035059.
根据世界卫生组织2013年标准,评估妊娠早期75克口服葡萄糖耐量试验(OGTT)对妊娠期糖尿病的预测性,并测试新提出的临界值。
国际前瞻性多中心队列研究。
2016年5月1日至2019年1月31日期间,奥地利、德国和瑞士的六个大学或州立部门。
829名年龄在18 - 45岁的低风险队列参与者,单胎妊娠,参加孕早期筛查并同意在妊娠12 - 15周时进行早期75克OGTT。参与者和医疗服务提供者对结果不知情。
早期75克OGTT(妊娠12 - 15周)和晚期75克OGTT(妊娠24 - 28周)后的空腹、1小时和2小时血糖浓度。
根据世界卫生组织2013年标准,在636名参与者中,74名(12%)在妊娠24 - 28周时患妊娠期糖尿病。将世界卫生组织2013年标准应用于至少有一个异常值的早期OGTT时,敏感性较低,为0.35(95%置信区间0.24至0.47),特异性较高,为0.96(置信区间0.95至0.98),阳性预测值为0.57(0.41至0.71),阴性预测值为0.92(0.89至0.94),阳性似然比为10.46(6.21至17.63),阴性似然比为0.65(0.55至0.78),诊断比值比为15.98(8.38至30.47)。降低负荷后血糖值(75克OGTT临界值为5.1、8.9和7.8毫摩尔/升)可提高检测率(53%,95%置信区间41%至64%)和阴性预测值(0.94,0.91至0.95),但在9%的假阳性率下会降低特异性(0.91,0.88至0.93)和阳性预测值(0.42,0.32至0.53)(阳性似然比5.59,4.0至7.81;阴性似然比0.64,0.52至0.77;诊断比值比10.07,6.26至18.31)。
这项前瞻性低风险队列研究的结果表明,在应用世界卫生组织2013年标准时,妊娠早期75克OGTT作为筛查工具不够敏感。妊娠合并糖尿病的早期妊娠中负荷后血糖值较高。降低负荷后临界值可识别出妊娠期糖尿病后期发生的高风险组或可能从早期治疗中获益的人群。显示早期干预有益效果的随机对照试验结果尚不清楚。
ClinicalTrials.gov NCT02035059